Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

A new rating scale for Alzheimer's disease

(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175 · see citing works

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · see citing works

Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview

Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 682 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works

Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial

DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 671 · see citing works

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644 · see citing works

Increase of Brain Oxidative Stress in Mild Cognitive Impairment

Praticò, D., Clark, C. M., Liun, F., Lee, V., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 587 · see citing works

Evidence of increased oxidative damage in subjects with mild cognitive impairment

Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539 · see citing works

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Mohs, R. C., Rosen, W. G., & Davis, K. L. (1983) · PubMed · Cited by 420 · see citing works

Book Review: Role of Superoxide Dismutases in Oxidative Damage and Neurodegenerative Disorders

Maier, C. M., & Chan, P. H. (2002) · The Neuroscientist · doi:10.1177/107385840200800408 · Cited by 324 · see citing works

Antioxidant Role of Glutathione S -Transferases: Protection Against Oxidant Toxicity and Regulation of Stress-Mediated Apoptosis

Sharma, R., Yang, Y., Sharma, A., Awasthi, S., & Awasthi, S. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604322899350 · Cited by 319 · see citing works

Mild Cognitive Impairment: A Systematic Review

Mariani, E., Monastero, R., & Mecocci, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12104 · Cited by 248 · see citing works

Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment

Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 247 · see citing works

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · see citing works

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245 · see citing works

Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease

Butterfield, D. A., Reed, T. T., Marzia Perluigi, A., Marco, C. M. D., Coccia, R., Keller, J. N., Markesbery, W. R., & Rukhsana Sultana, A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.084 · Cited by 238 · see citing works

Superoxide dismutase--applications and relevance to human diseases.

Noor, R., Mittal, S., & Iqbal, J. (2002) · PubMed · Cited by 238 · see citing works

Formation of monohydroxy-polyenic fatty acids from lipid peroxides by a glutathione peroxidase

Christophersen, B. O. (1968) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(68)90068-4 · Cited by 234 · see citing works

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

Bourdel‐Marchasson, I. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.235 · Cited by 215 · see citing works

Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type

Ishrat, T., Parveen, K., Khan, M. M., Khuwaja, G., Khan, M. B., Yousuf, S., Ahmad, A., Shrivastav, P., & Islam, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.010 · Cited by 199 · see citing works

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

Bermejo‐Bescós, P., Martín‐Aragón, S., Benedı́, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. (2008) · Free Radical Research · doi:10.1080/10715760701861373 · Cited by 167 · see citing works

Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157 · see citing works

Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease

Greilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., & Oettl, K. (2008) · Free Radical Research · doi:10.1080/10715760802255764 · Cited by 149 · see citing works

Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type—Place of the extracellular glutathione peroxidase

Ceballos-Picot, I., Merad-Boudia, M., Nicole, A., Thévenin, M., Hellier, G., Legrain, S., & Berr, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02058-6 · Cited by 130 · see citing works

Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease

Kawamoto, E. M., Munhoz, C. D., Glezer, I., Bahia, V. S., Caramelli, P., Nitríni, R., Gorjão, R., Curi, R., Scavone, C., & Marcourakis, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.011 · Cited by 129 · see citing works

Circulating Biomarkers of Cognitive Decline and Dementia

Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120 · see citing works

Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment

Rukhsana Sultana, A., Piroddi, M., Galli, F., & Butterfield, D. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9593-0 · Cited by 115 · see citing works

Concepts of mild memory impairment in the elderly and their relationship to dementia—a review

Dawe, B., PROCTER, A. W., & Philpot, M. P. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070704 · Cited by 99 · see citing works

Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer?s disease brain

Schüssel, K., Leutner, S., Cairns, N. J., M�ller, W. E., & Eckert, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0156-5 · Cited by 95 · see citing works

Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment

Beal, M. F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.022 · Cited by 93 · see citing works

Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients

Galbusera, C., Facheris, M., Magni, F., Galimberti, G., Sala, G., Tremolada, L., Isella, V., Guerini, F. R., Appollonio, I. M., Galli-Kienle, M., et al. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332171 · Cited by 68 · see citing works

α,β-Unsaturated Aldehydes Increase GlutathioneS-Transferase mRNA and Protein: Correlation with Activation of the Antioxidant Response Element

Tjalkens, R. B., Luckey, S. W., Kroll, D. J., et al. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0895 · Cited by 67 · see citing works

Alternative Medicine and Alzheimer Disease

Kelley, B. J., & Knopman, D. S. (2008) · The Neurologist · doi:10.1097/nrl.0b013e318172cf4d · Cited by 61 · see citing works

Influence of Thyroid Hormone on Thyroid Hormone Receptor β-1 Expression and Lacrimal Gland and Ocular Surface Morphology

Dias, A. C., ́dulo, C. M. M., Jorge, A. G., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1309 · Cited by 60 · see citing works

Antioxidants for the treatment of mild cognitive impairment

Mecocci, P., Mariani, E., Cornacchiola, V., & Polidori, M. C. (2004) · Neurological Research · doi:10.1179/016164104225017659 · Cited by 55 · see citing works

Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey

Aybek, H., Ercan, F., Aslan, D., & Şahiner, T. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.09.005 · Cited by 48 · see citing works

Vitamin A and lipid peroxidation in patients with different forms of leprosy

Lima, É. S., Roland, I. D. A., Marója, M. D. F., et al. (2007) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652007000400003 · Cited by 22 · see citing works

Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging

Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Oxidative Stress and the Pathogenesis of Alzheimer's Disease

Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855 · see citing works

HPA Axis in the Pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation

Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450 · see citing works

Exercise benefits on Alzheimer’s disease: State-of-the-science

Valenzuela, P. L., Castillo-García, A., Morales, J. S., de la Villa, P., Hampel, H., Emanuele, E., Lista, S., & Lucia, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101108 · Cited by 337 · see citing works

Inflammatory theory of depression

Gałecki, P., & Talarowska, M. (2018) · Psychiatria Polska · doi:10.12740/pp/76863 · Cited by 192 · see citing works

The relevance of oxidative stress status in first episode and recurrent depression

Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179 · see citing works

The emerging role of glutathione in Alzheimer’s disease

Saharan, S., & Mandal, P. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132483 · Cited by 168 · see citing works

Oxidant/antioxidant imbalance and the risk of Alzheimer's disease

Moneim, A. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150325182702 · Cited by 136 · see citing works

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation

Barone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127 · see citing works

Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease

Sharma, A., Weber, D., Raupbach, J., Dakal, T. C., Fließbach, K., Ramirez, A., Grune, T., & Wüllner, U. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101546 · Cited by 120 · see citing works

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works

Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus

Bild, W., Hritcu, L., Stefanescu, C., & Ciobica, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.009 · Cited by 83 · see citing works

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men

Ma, C., Li, J., Bao, Z., Ruan, Q., & Yu, Z. (2015) · BioMed Research International · doi:10.1155/2015/481621 · Cited by 46 · see citing works

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer’s Disease: A Narrative Review

Zimetti, F., Adorni, M. P., Marsillach, J., Marchi, C., Trentini, A., Valacchi, G., & Cervellati, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6695796 · Cited by 49 · see citing works

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47 · see citing works

The interdependence of the reactive species of oxygen, nitrogen, and carbon

Bild, W., Ciobica, A., Padurariu, M., & Bild, V. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0162-2 · Cited by 44 · see citing works

Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer's Disease

Abate, G., Vezzoli, M., Sandri, M., Rungratanawanich, W., Memo, M., & Uberti, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111385 · Cited by 41 · see citing works

An immune gate of depression—Early neuroimmune development in the formation of the underlying depressive disorder

Kowalczyk, M., Szemraj, J., Bliźniewska, K., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.022 · Cited by 38 · see citing works

Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer’s disease in Wistar rats

Rajkumar, M., Sakthivel, M., Senthilkumar, K., Thangaraj, R., & Kannan, S. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100100 · Cited by 29 · see citing works

Update on the neurodevelopmental theory of depression: is there any 'unconscious code'?

Gałecka, M., Bliźniewska-Kowalska, K., Maes, M., Su, K.-P., & Gałecki, P. (2021) · Pharmacological Reports · doi:10.1007/s43440-020-00202-2 · Cited by 27 · see citing works

Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease

McIntyre, J. A., Ramsey, C. J., Gitter, B. D., Saykin, A. J., Wagenknecht, D. R., Hyslop, P. A., & Initiative, F. T. A. D. N. (2015) · Autoimmunity · doi:10.3109/08916934.2015.1008464 · Cited by 22 · see citing works

Importance of the lipid peroxidation biomarkers and methodological aspects FOR malondialdehyde quantification

Grotto, D., Maria, L. S., Valentini, J., et al. (2009) · Química Nova · doi:10.1590/s0100-40422009000100032 · Cited by 432 · see citing works

[Malondialdehyde (MDA) as a lipid peroxidation marker].

Gaweł, S., Wardas, M., Niedworok, E., et al. (2004) · PubMed · Cited by 852 · see citing works

Paraquat and lipid peroxidation.

Daugherty, J. P. (1982) · PubMed · Cited by 1 · see citing works

An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples

Breusing, N., Grune, T., Andrišić, L., Atalay, M., Bartosz, G., Biasi, F., Borović, S., Bravo, L., Casals, I., Casillas, R., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.499907 · Cited by 66 · see citing works

Optimized steps in determination of malondialdehyde (MDA) standards on diagnostic of lipid peroxidation

Fauziah, P. N., Maskoen, A. M., Yuliati, T., & Widiarsih, E. (2018) · Padjadjaran Journal of Dentistry · doi:10.24198/pjd.vol30no2.18329 · Cited by 21 · see citing works